Neurodoron

Neurodoron is an anthroposophic and complementary medicine developed by Weleda AG, indicated for the treatment of neurasthenia (nervous exhaustion) and metabolic weakness. It is a multi-component preparation containing three active ingredients: Aurum metallicum praeparatum (prepared gold), Kalium phosphoricum (potassium phosphate), and Ferrum-Quarz (iron-quartz). Originally launched in 1954 as Kalium phosphoricum comp., it was rebranded as Neurodoron in 2007. The drug is intended to address symptoms such as nervousness, irritability, restlessness, anxiety, and sleep disorders. As an anthroposophic medicine, it does not target a specific biological receptor in the conventional pharmacological sense but is designed to harmonize the human organism according to anthroposophic principles. It has been evaluated in Phase IV clinical trials in Germany to confirm its efficacy and safety in patients with nervous exhaustion.

Brand names

Neurodoron

Other names

Kalium phosphoricum comp.